Weak pharma growth in Q2 sparks concerns

Weakness in domestic growth is driven by slow growth in the acute segment

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.